A novel immunoscintigraphy technique using metabolizable linker with angiotensin II treatment
1999

New Imaging Technique for Tumors Using Angiotensin II

publication

Author Information

Author(s): Nakamoto Y, Sakahara H, Saga T, Sato N, Zhao S, Arano Y, Fujioka Y, Saji H, Konishi J

Primary Institution: Graduate School of Medicine, Kyoto University Hospital

Hypothesis

Can a new linker with antibody fragments improve tumor imaging soon after injection of a radiolabelled reagent in conditions of induced hypertension in mice?

Conclusion

The study found that using a novel linker with angiotensin II treatment significantly improved tumor imaging by enhancing tumor-to-normal tissue ratios.

Supporting Evidence

  • The new linker improved tumor targeting and imaging.
  • Angiotensin II treatment increased tumor radioactivity approximately two-fold.

Takeaway

Researchers developed a new way to take pictures of tumors that works better and faster by using a special chemical and a treatment that raises blood pressure.

Methodology

Murine monoclonal antibody fragments were labeled and injected into tumor-bearing mice, with angiotensin II administered to enhance imaging.

Participant Demographics

Tumor-bearing mice were used in the study.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6990286

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication